Welcome to Business Insider‘s daily healthcare newsletter, your daily dose of pharma, biotech, and healthcare news. Subscribe here to get this newsletter in your inbox every weekday.
Hello,
Today in healthcare news: why Wall Street analyst thinks two of the healthcare stocks pummeled by the news of Amazon Pharmacy will explode, BI Deutschland’s interview with BioNTech’s CEO, and Moderna salaries revealed.
Wall Street analysts say buy these 2 healthcare stocks spring-loaded for gains after getting pummeled by Amazon Pharmacy — including one poised to surge 81%
- On Tuesday, Amazon launched Amazon Pharmacy, its long-awaited push into prescription drugs.
- It sent healthcare stocks tumbling, including wholesalers, health plans, and pharmacies.
- But two companies — GoodRx and AmerisourceBergen — were too caught up in the sell-off, Wall Street analysts said.
Read the full story from Blake Dodge here>>
We spoke to BioNTech's CEO about how the firm made an effective COVID-19 vaccine so fast and when he plans to get vaccinated
- Little-known biotech firm BioNTech made headlines after the long-awaited phase three data for its vaccine with Pfizer arrived, indicating the first effective coronavirus shot.
- BioNTech and Pfizer want to apply for emergency approval in the US this month.
- Business Insider spoke to BioNTech CEO Ugur Sahin about how the company approached vaccine development at speed without taking any shortcuts.
Read the full story from our Business Insider Deutschland colleagues here>>
Moderna salaries revealed: From $60,000 to $250,000, here's how much you could make at the biotech firm that recently announced a successful COVID-19 vaccine
- Biotech firm Moderna announced a success in initial coronavirus vaccine trials Monday morning, with a reported effective rate of 94.5%. This follows Pfizer's similar announcement from a week prior.
- The firm currently has 163 job openings listed on LinkedIn. Using data from the US Office of Foreign Labor Certification, Business Insider analyzed salary information for Moderna employees to provide a look at how the firm pays.
- Most data we reviewed were for engineering and scientist positions, and spanned many different areas within the health and pharmaceuticals realm — bioinformatics, drug processing, DNA, and in vitro research were among the subject areas listed.
- Pay ranged from around $60,000 for research associates to $250,000 for program directors.
Read the full story from Maddy Simpson here>>
More stories we're reading:
- Pfizer's and Moderna's vaccines likely work for all existing coronavirus strains. Don't worry about mutations for now, scientists say. (Business Insider)
- "We don't really want to see Mamaw at Thanksgiving and bury her by Christmas," Mississippi health expert warns (Mississippi Free Press)
- Moderna's coronavirus vaccine doesn't need to be as icy cold as Pfizer's, and that could make it easier to distribute (Business Insider)
- New York is closing schools again as coronavirus cases surge (New York Daily News)
- Walmart is rolling out COVID testing for all workers in New Mexico, requiring employees to get tested every 2 weeks (Business Insider)
Have you subscribed to our newsletter yet? Click here to get daily headlines from Business Insider's healthcare team in your inbox.
- Lydia